Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Jently vs Trimrose

Jently
Graded #178

Higher grade

vs+11.799999999999997
Trimrose
Graded #446

Lower grade

The verdict

Jently takes it — 67/100 to 55.2/100.

Jently grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Jently is a clinician-guided telehealth service offering compounded GLP-1 weight management (semaglutide from $149/mo, tirzepatide from $199/mo) alongside NAD+, peptide therapy (sermorelin, glutathione),…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueJently +35
74
39
Dose & formulationEven
64
64
Clinical oversightJently +11
79
68
Labs & monitoringEven
52
52
FulfillmentJently +10
67
57
Contract termsTrimrose +4
51
55
Jently · left barTrimrose · right bar

The numbers

MetricJentlyTrimrose
WeighScore67/10055.2/100
GradeCC
Scorecard rank#178#446
Semaglutide$149/mo (starting dose, compounded)Not disclosed
Tirzepatide$199/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Jently

Graded #178 · C

Strengths

  • Compounded semaglutide from $149/mo and tirzepatide from $199/mo — pricing published
  • Multi-pillar: GLP-1, NAD+, peptides (sermorelin, glutathione), and metformin
  • 100% online with licensed providers via the MD Integrations network
  • Subscription can be cancelled anytime through the patient portal

Where it loses points

  • Specific pharmacy partner not named on the site
  • No refunds once a consultation is completed or a prescription is dispensed
  • Not LegitScript-certified (no certification displayed)
  • States of operation not published
Trimrose

Graded #446 · C

Strengths

  • Free, no-cost, no-obligation online eligibility quiz before any commitment
  • Offers a choice of a weekly compounded GLP-1 injection or a daily oral option
  • Fully online — assessment, provider review, and home delivery with ongoing support

Where it loses points

  • Runs on the CareValidate white-label platform and isn't the medical provider itself — a support@carevalidate.com address is exposed on the site
  • Pricing isn't shown publicly; the cost and the specific compounded molecule appear only after you complete the eligibility quiz
  • The states served, pharmacy partner and any LegitScript/503A certification aren't disclosed on the public site
  • Markets 'up to 22.5% of body weight' — a trial figure for branded tirzepatide, not a guaranteed or compounded-specific outcome
  • Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard